PROOF Trial: Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangio
- This topic has 0 replies, 1 voice, and was last updated 4 years, 7 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
PROOF Trial: Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations
https://clinicaltrials.gov/ct2/show/NCT03773302
Gavin
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.